Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Revenue (2023 - 2025)

CervoMed's Revenue history spans 8 years, with the latest figure at $322569.0 for Q3 2025.

  • For Q3 2025, Revenue fell 83.37% year-over-year to $322569.0; the TTM value through Sep 2025 reached $6.2 million, down 38.81%, while the annual FY2024 figure was $9.7 million, 36.29% up from the prior year.
  • Revenue for Q3 2025 was $322569.0 at CervoMed, down from $1.8 million in the prior quarter.
  • Across five years, Revenue topped out at $3.3 million in Q2 2024 and bottomed at $322569.0 in Q3 2025.
  • The 3-year median for Revenue is $1.9 million (2025), against an average of $1.9 million.
  • The largest annual shift saw Revenue soared 91.23% in 2024 before it plummeted 83.37% in 2025.
  • A 3-year view of Revenue shows it stood at $2.5 million in 2023, then dropped by 13.19% to $2.2 million in 2024, then plummeted by 85.08% to $322569.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Revenue are $322569.0 (Q3 2025), $1.8 million (Q2 2025), and $1.9 million (Q1 2025).